Ropinirole Tablet, Film Coated, Extended Release
Product Images NDC 0228-3658

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Ropinirole (NDC 0228-3658). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Ropinirole 8 mg extended-release film-coated tablets, circular with a yellow color. The tablets are embossed with the number 0 over the word ROPI. The image shows two tablets side-by-side on a white background.*

FDA Label Image

Image 10

Chemical structure of ropinirole displayed as a line-bond diagram showing its molecular framework.*

FDA Label Image

Image 11

Chemical structure of Ropinirole, the active ingredient in the film-coated extended-release tablets by Actavis Pharma, Inc. The diagram shows the molecular arrangement and bonds of the compound used in this prescription drug.*

FDA Label Image

Image 12

Ropinirole Extended-Release Tablets, USP 2 mg film-coated extended-release oral tablets. The label displays the 2 mg strength with a pink, elliptical tablet pictured. Packaged by Actavis Pharma, Inc., it contains 30 tablets and includes prescription information and storage instructions.*

FDA Label Image

Image 13

Ropinirole 4 mg Extended-Release Tablets, USP, film-coated, oral dosage form. The label indicates 30 tablets per container. It includes the NDC 0228-3659-03 and manufacturer Actavis Elizabeth LLC, Elizabeth, NJ. The label also shows an image of an oval, white film-coated tablet with imprint "G 659."*

FDA Label Image

Image 14

Ropinirole 6 mg Extended-Release Tablets, USP oral film-coated tablets in a bottle label. The label shows 30 film-coated tablets, manufactured by Actavis Elizabeth LLC and distributed by Actavis Pharma, Inc. It includes the NDC 0228-3640-03, barcode, pill imprint, and storage instructions.*

FDA Label Image

Image 15

Label for Ropinirole Extended-Release Tablets, USP 8 mg from Actavis Pharma, Inc. The image shows a pink, oval, film-coated tablet imprinted with '660'. The bottle contains 30 extended-release tablets. The label includes storage instructions, manufacturer and distributor information, and a barcode.*

FDA Label Image

Image 16

Ropinirole 12 mg Extended-Release Tablets, USP label from Actavis Pharma, Inc. This carton contains 30 film-coated extended-release tablets for oral use. The label notes the strength as 12 mg of ropinirole per tablet and includes storage instructions along with manufacturer and distributor details.*

FDA Label Image

Image 2

Ropinirole 12 mg extended-release film-coated tablets are shown in a blister pack with a silver foil backing. Each tablet is round and white. The labeler is Actavis Pharma, Inc. The packaging shows 10 tablets arranged in two rows of five.*

FDA Label Image

Image 3

Ropinirole extended release film-coated tablets in multiple strengths, including 2 mg, 4 mg, 6 mg, 8 mg, and 12 mg, shown on a blister card. The packaging includes Actavis Pharma, Inc. as the labeler, with individual tablets numbered and arranged in two columns.*

FDA Label Image

Image 4

The image shows a blister pack for Ropinirole extended-release tablets. The tablets are film-coated and round, with alternating colors of pink and beige. The pack contains ten tablets arranged in two rows of five, and part of the packaging includes the brand and dosage information.*

FDA Label Image

Image 5

Ropinirole 12 mg extended-release film-coated tablets blister pack. The image shows five oval, light brown tablets arranged in a single row inside transparent packaging. Each tablet is scored and the pack is labeled with the dosage strength, product name, and manufacturing information from Actavis Pharma, Inc.*

FDA Label Image

Image 6

Chemical structure of Ropinirole hydrochloride, showing the molecular framework of the active ingredient typically used in extended-release oral tablets for prescription use.*

FDA Label Image

Image 7

Ropinirole 12 mg extended-release film-coated tablet. The tablet is round, biconvex, white, and debossed with the number '622' on one side. The labeler is Actavis Pharma, Inc.*

FDA Label Image

Image 8

FDA Label Image

Image 9

Chemical structure of ropinirole, an active ingredient in the prescription extended-release film-coated tablet form labeled by Actavis Pharma, Inc. The structure shows the molecular arrangement characteristic of ropinirole.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.